Scan­gos left Bio­gen in style, tak­ing a fi­nal $17.7M com­pen­sa­tion pack­age for one last, dis­ap­point­ing year

When George Scan­gos left Bio­gen at the end of 2016, he left be­hind a fad­ing megablock­buster fran­chise he had helped cre­ate and passed the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA